http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105030719-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
| filingDate | 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105030719-B |
| titleOfInvention | A kind of composition containing Egelieting and Pioglitazone |
| abstract | The present invention provides a kind of composition containing Egelieting and Pioglitazone, is made of label, barrier layer and outer layer.The weight percent of each layer matches：Label accounts for 13%~33%, and barrier layer accounts for 0.4%~10%, and outer layer accounts for 60%~85%.When containing Egelieting in label, contain Pioglitazone in outer layer；When containing Pioglitazone in label, contain Egelieting in outer layer.Wherein, Egelieting accounts for the 2.5%~10% of total tablet weight, and Pioglitazone accounts for the 3%~16% of total tablet weight.Simple production process of the present invention is reliable, loss less and the stability of product is good, by-product is few, therefore is conducive to industrialized production. |
| priorityDate | 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.